A regional specialty pharmacy chain described its approach in a trade article: they embedded a CoverMyMeds link directly into their pharmacy software
This part of the study may be the most clinically informative
The next #frontier may be metabolic health, where inflammation, insulin sensitivity, appetite regulation, mitochondrial function, and healthy aging all connect through the endocannabinoid system
ADA Recommendations for GLP-1 RA in T2DM Patients The GLP-1 receptor agonists, with or without metformin based on glycemic needs, are appropriate initial therapy for patients with type 2 diabetes mellitus (T2DM) with or at high risk for atherosclerotic cardiovascular disease (ASCVD)/indicators of high-risk, heart failure (HF), or chronic kidney disease (CKD)
BPC-157 is an unlicensed medicine